CytomX Therapeutics, Inc.
CTMX
$2.03
$0.031.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 97.89% | -20.61% | -14.43% | -14.28% | -8.72% |
| Total Receivables | -4.45% | -36.96% | -7.43% | 20.79% | -78.94% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -2.53% | 33.72% | 10.46% | 3.75% | -17.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 90.03% | -19.27% | -13.59% | -13.21% | -14.45% |
|
|
|||||
| Total Current Assets | 90.03% | -19.27% | -13.59% | -13.21% | -14.45% |
| Net Property, Plant & Equipment | -14.98% | -12.44% | -12.62% | -10.38% | -8.51% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -6.76% | -6.17% | -5.97% | -5.49% | -5.34% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.46% | -0.37% | -0.36% | 10.47% | -0.40% |
| Total Assets | 77.73% | -18.28% | -13.27% | -12.71% | -13.79% |
|
|
|||||
| Total Accounts Payable | -17.75% | -74.63% | -23.49% | 132.73% | -68.89% |
| Total Accrued Expenses | 7.49% | -14.48% | -26.31% | 22.92% | -4.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.83% | 2.88% | 2.88% | 2.88% | 2.90% |
| Total Finance Division Other Current Liabilities | -34.83% | -49.28% | -30.04% | -22.38% | 0.11% |
| Total Other Current Liabilities | -34.83% | -49.28% | -30.04% | -22.38% | 0.11% |
| Total Current Liabilities | -21.87% | -41.47% | -28.06% | -16.54% | -1.16% |
|
|
|||||
| Total Current Liabilities | -21.87% | -41.47% | -28.06% | -16.54% | -1.16% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -49.51% | -32.64% | -24.23% | -18.72% | -15.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -28.98% | -34.17% | -17.63% | -7.60% | -36.08% |
| Total Liabilities | -24.92% | -39.29% | -25.51% | -14.71% | -11.98% |
|
|
|||||
| Common Stock & APIC | 13.70% | 0.29% | 0.60% | 0.29% | 1.03% |
| Retained Earnings | -0.02% | 3.40% | 2.66% | 0.80% | -0.92% |
| Treasury Stock & Other | 3,400.00% | -103.70% | -32.50% | 1,100.00% | 60.00% |
| Total Common Equity | 378.70% | 5,593.20% | 98.06% | 24.90% | 1.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 378.70% | 5,593.20% | 98.06% | 24.90% | 1.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 378.70% | 5,593.20% | 98.06% | 24.90% | 1.43% |
|
|
|||||